The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Open accessAbstract
Several clinical trials have recently targeted specific pathways implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, IPF remains plagued by a median survival of 3 yrs and emphasises the need for further research with new insights and perspectives. The prevailing pathogenic hypotheses assume that either an inflammatory process or an independent epithelial/fibroblastic disorder may propagate the disease process. Based on knowledge developed with considerable scientific evidence, we provide our perspectives with an alternative point of view that IPF be considered as a neoproliferative disorder of the lung. Genetic alterations, response to growth and inhibitory signals, resistance to apoptosis, myofibroblast origin and behaviour, altered cellular communications, and intracellular signalling pathways are all fundamental pathogenic hallmarks of both IPF and cancer. The concept of IPF as a lethal malignant disorder of the lung might extend beyond the pathogenic link between these two diseases and disclose new pathogenic mechanisms leading to novel therapeutic options, adopted from cancer biology. Moreover, this vision might dawn the awareness of the public, political and scientific community of this devastating disease from an angle different from the current perception and provoke new ideas and studies to get a better understanding to control the otherwise relentless progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Self-citationKim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Oxidative stress and regulation of glutathione in lung inflammation
Rahman, I., & MacNee, W. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003534.x · Cited by 923
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Self-citationBone Marrow–Derived Mesenchymal Stem Cells in Repair of the Injured Lung
Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J., & Brigham, K. L. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0330oc · Cited by 848
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Self-citationAberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Self-citationOxidative stress, DNA methylation and carcinogenesis
Franco, R., Schoneveld, O., Georgakilas, A. G., & Panayiotidis, M. I. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.026 · Cited by 603
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573
Self-citationKing, T. E., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60551-1 · Cited by 531
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
The Myofibroblast in Pulmonary Fibrosis*
Phan, S. H. (2002) · Chest · doi:10.1378/chest.122.6_suppl.286s · Cited by 521
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500
Self-citationEpithelial Origin of Myofibroblasts during Fibrosis in the Lung
Willis, B. C., duBois, R. M., & Borok, Z. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-004tk · Cited by 500
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Olson, A. L., Swigris, J. J., Lezotte, D. C., Norris, J. M., Wilson, C. G., & Brown, K. K. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-044oc · Cited by 435
DANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
Self-citationEvolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 344
Kuwano, K., Kunitake, R., Kawasaki, M., Nomoto, Y., Hagimoto, N., Nakanishi, Y., & Hara, N. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.154.2.8756825 · Cited by 339
Tang, J.-M., He, Q.-Y., Guo, R.-X., & Chang, X.-J. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.10.003 · Cited by 332
Nicholson, A. G., Fulford, L. G., Colby, T. V., du Bois, R. M., Hansell, D. M., & Wells, A. U. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109039 · Cited by 299
BEHR, J., MAIER, K., DEGENKOLB, B., KROMBACH, F., & VOGELMEIER, C. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9706065 · Cited by 283
The role of circulating fibrocytes in fibrosis
Quan, T. E., Cowper, S. E., & Bucala, R. (2006) · Current Rheumatology Reports · doi:10.1007/s11926-006-0055-x · Cited by 263
Shepherd, F. A., Giaccone, G., Seymour, L., Debruyne, C., Bezjak, A., Hirsh, V., Smylie, M., Rubin, S., Martins, H., Lamont, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.108 · Cited by 262
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., & Strieter, R. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.149 · Cited by 255
HSP27 and HSP70: Potentially Oncogenic Apoptosis Inhibitors
Garrido, C., Schmitt, E., Candé, C., Vahsen, N., Parcellier, A., & Kroemer, G. (2003) · Cell Cycle · doi:10.4161/cc.2.6.521 · Cited by 252
Mazieres, J., He, B., You, L., Xu, Z., & Jablons, D. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.040 · Cited by 244
Targeting the TGFβ signaling network in human neoplasia
Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 242
Mori, R., Power, K. T., Wang, C. M., Martin, P., & Becker, D. L. (2006) · Journal of Cell Science · doi:10.1242/jcs.03320 · Cited by 240
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239
Thy-1 Promoter Hypermethylation: A Novel Epigenetic Pathogenic Mechanism in Pulmonary Fibrosis
Sanders, Y. Y., Pardo, A., Selman, M., Nuovo, G. J., Tollefsbol, T. O., Siegal, G. P., & Hagood, J. S. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0322oc · Cited by 235
Jordana, M., Schulman, J., McSharry, C., Irving, L. B., Newhouse, M. T., Jordana, G., & Gauldie, J. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.3.579 · Cited by 233
De Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M., & Berx, G. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0464-1 · Cited by 229
CARACI, F., GILI, E., CALAFIORE, M., FAILLA, M., LAROSA, C., CRIMI, N., SORTINO, M., NICOLETTI, F., COPANI, A., & VANCHERI, C. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.001 · Cited by 203
Self-citationFibroblast Foci Are Not Discrete Sites of Lung Injury or Repair: The Fibroblast Reticulum
Cool, C. D., Groshong, S. D., Rai, P. R., Henson, P. M., Stewart, J. S., & Brown, K. K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-205oc · Cited by 196
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., lannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600731 · Cited by 174
Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
Tian, B., Lessan, K., Kahm, J., Kleidon, J., & Henke, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203565200 · Cited by 166
A role for Wnt-4 in renal fibrosis
Surendran, K., McCaul, S. P., & Simon, T. C. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0009.2001 · Cited by 164
Shi‐wen, X., Kennedy, L., Renzoni, E. A., Bou‐Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D. J., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 163
Enhanced Myofibroblastic Differentiation and Survival in Thy-1(−) Lung Fibroblasts
Sanders, Y. Y., Kumbla, P. A., & Hagood, J. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0178oc · Cited by 159
Raghu, G., Masta, S. E., Meyers, D., & Narayanan, A. S. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.1.95 · Cited by 153
Self-citationDifferential Proliferation of Fibroblasts Cultured from Normal and Fibrotic Human Lungs
Raghu, G., Chen, Y., Rusch, V. W., & Rabinovitch, P. S. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.703 · Cited by 147
Self-citationTherapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare
Corsten, M. F., & Shah, K. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70099-8 · Cited by 138
Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
Moore, B. B., Ballinger, M. N., White, E. S., Green, M. E., Herrygers, A. B., Wilke, C. A., Toews, G. B., & Peters-Golden, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5644 · Cited by 135
β-Catenin Signaling in Fibroproliferative Disease
Bowley, E., O’Gorman, D. B., & Gan, B. S. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.07.026 · Cited by 119
Many different tumor types have polyclonal tumor origin: Evidence and implications
Parsons, B. L. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.05.004 · Cited by 118
McAnulty, R. J., Hernández-Rodríguez, N. A., Mutsaers, S. E., Coker, R. K., & Laurent, G. J. (1997) · Biochemical Journal · doi:10.1042/bj3210639 · Cited by 114
Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Liu, T., Chung, M. J., Ullenbruch, M. R., Yu, H., Jin, H., Hu, B., Choi, Y. Y., Ishikawa, F., & Phan, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32369 · Cited by 113
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis
Chilosi, M., Zamò, A., Doglioni, C., Reghellin, D., Lestani, M., Montagna, L., Pedron, S., Ennas, M. G., Cancellieri, A., Murer, B., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-95 · Cited by 111
Desmoid tumor: a disease opportune for molecular insights.
Kotiligam, D., Lazar, A. J., Pollock, R. E., & Lev, D. C. (2008) · PubMed · doi:10.14670/hh-23.117 · Cited by 110
Avanzo, J. L., Mesnil, M., Hernandez‐Blazquez, F. J., Mackowiak, I. I., Mori, C. M. C., da Silva, T. C., Oloris, S. C. S., Gárate, A. P., Massironi, S. M. G., Yamasaki, H., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh193 · Cited by 107
Quantitative Analysis of Fibroblastic Foci in Usual Interstitial Pneumonia
Enomoto, N., Suda, T., Kato, M., Kaida, Y., Nakamura, Y., Imokawa, S., Ida, M., & Chida, K. (2006) · CHEST Journal · doi:10.1378/chest.130.1.22 · Cited by 105
Saed, G. M., Ladin, D. A., Olson, J., Han, X., Hou, Z., & Fivenson, D. P. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.8.963 · Cited by 102
Cross-Talk Between Pulmonary Injury, Oxidant Stress, and Gap Junctional Communication
Johnson, L. N., & Koval, M. H. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2183 · Cited by 101
Antioxidant Therapy for Idiopathic Pulmonary Fibrosis
Hunninghake, G. W. (2005) · New England Journal of Medicine · doi:10.1056/nejme058210 · Cited by 97
Vancheri, C., Sortino, M. A., Tomaselli, V., Mastruzzo, C., Condorelli, F., Bellistrı́, G., Pistorio, M. P., Canonico, P. L., & Crimi, N. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.5.3948 · Cited by 96
Self-citationCesen-Cummings, K., Fernstrom, M. J., Malkinson, A. M., & Ruch, R. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.61 · Cited by 92
Catlett, J., & Alving, B. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-2-200201150-00011 · Cited by 89
Demopoulos, K., Arvanitis, D. A., VASSILAKIS, D. A., Siafakas, N. M., & Spandidos, D. A. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00188.x · Cited by 81
Duan, X., Guan, H., Cao, Y., & Kleinerman, E. S. (2009) · Cancer · doi:10.1002/cncr.24013 · Cited by 79
Lyons, J. G., Lobo, E. P., Martorana, A., & Myerscough, M. R. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9134-2 · Cited by 68
Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
Uematsu, K., Yoshimura, A., Gemma, A., Mochimaru, H., Hosoya, Y., Kunugi, S., Matsuda, K., Seike, M., Kurimoto, F., Takenaka, K., et al. (2001) · PubMed · Cited by 68
Salinaro, A. T., Salinaro, E. T., Failla, M., Mastruzzo, C., Tomaselli, V., Gili, E., Crimi, N., Condorelli, D. F., & Vancheri, C. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-122 · Cited by 66
Self-citationHeterogeneous point mutations of the p53 gene in pulmonary fibrosis
Hojo, S., Fujita, J., Yamadori, I., Kamei, T., Yoshinouchi, T., OHTSUKI, Y., Okada, H., Bandoh, S., Yamaji, Y., Takahara, J., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061404 · Cited by 55
Sheffer, Y., Leon, O., Pinthus, J. H., Nagler, A., Mor, Y., Genin, O., Iluz, M., Kawada, N., Yoshizato, K., & Pines, M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0468 · Cited by 53
Masaki, T., Sugiyama, M., Matsuoka, H., Abe, N., Izumisato, Y., Sakamoto, A., & Atomi, Y. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1024142722640 · Cited by 38
Epstein–Barr virus and wild p53 in idiopathic pulmonary fibrosis
Lok, S., Stewart, J. P., Kelly, B. G., Hasleton, P. S., & Egan, J. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1152 · Cited by 36
Commentary: Antioxidants for Cancer: New Tricks for an Old Dog?
Sharifi, N. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0219 · Cited by 10
Davidsson, J., Paulsson, K. M., & Johansson, B. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.05.013 · Cited by 8
Cited by
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Self-citationPulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
George, P. M., Wells, A. U., & Jenkins, R. G. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30225-3 · Cited by 1,085
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Burgstaller, G., Oehrle, B., Gerckens, M., White, E. S., Schiller, H. B., & Eickelberg, O. (2017) · European Respiratory Journal · doi:10.1183/13993003.01805-2016 · Cited by 482
Association Between Interstitial Lung Abnormalities and All-Cause Mortality
Putman, R. K., Hatabu, H., Araki, T., Gudmundsson, G., Gao, W., Nishino, M., Okajima, Y., Dupuis, J., Latourelle, J. C., Cho, M. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.0518 · Cited by 473
Metadata
- Authors
- Vancheri, C., Failla, M., Crimi, N., & Raghu, G.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2010-02-28
- Volume
- 35
- Issue
- 3
- Pages
- 496-504
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2114970103
- Cited by
- 464
- References
- 78
- FWCI
- 18.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.